REFERENCES
- Martin LJ, Al-Abdulla NA, Brambrink AM, Kirsch JR, Sieber FE, Portera-Cailliau C. Neurodegeneration in excitotoxicity, global cerebral ischemia, and target deprivation: a perspective on the contributions of apoptosis and necrosis. Brain Res Bull 1998; 46: 281–309.
- Li S, Stys PK. Mechanisms of ionotropic glutamate receptor-mediated excitotoxicity in isolated spinal cord white matter. J Neurosci 2000; 20: 1190–1198.
- Kowa11 NW, Rosen BR, Beal MF. Involvement of free radicals in excitotoxicity in vivo. J Neurochem 1995; 64: 2239-2247.
- Carriedo SG, Yin HZ, Sensi SL, Weiss JH. Rapid Ca' entry through Ca'-permeable AMPA/kainate channels triggers marked intracellular Ca' rises and consequent oxygen radical production. J Neurosci 1998; 18: 7727–7738.
- Sureda FX, Camins A, Pallas M, Trullas R, Escubedo E, Camarasa J. Reactive oxygen production by glutamate agonists in dissociated cerebellar cells: a flow cytometric study. Gen Pharmacol 1998; 30: 507–511.
- Shimizu-Sasamata M, Kano T, Rogowska J, Wolf GL, Moskowitz MA, Lo EH. YM872, a highly water-soluble AMPA receptor antagonist, preserves the hemodynamic penumbra and reduces brain injury after permanent focal ischemia in rats. Stroke 1998; 29: 2141–2148.
- Stieg PE, Sathi S, Warach S, Le DA, Lipton SA. Neuroprotection by the NMDA receptor-associated open-channel blocker memantine in a photothrombotic model of cerebral focal ischemia in neonatal rat. Eur J Pharmacol 1999; 375: 115–120.
- Wada S, Yone K, Ishidou Y et al. Apoptosis following spinal cord injury in rats and preventative effect of N-methyl-D-aspartate receptor antagonist. J Neurosurg 1999; 91: S98–S104.
- Rosenberg LJ, Teng YD, Wrathall JR. 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline reduces glial loss and acute white matter pathology after experimental spinal cord contusion. J Neurosci 1999; 19: 464–475.
- Yang CS, Tsai PJ, Lin NN, Kuo JS. Elevated extracellular glutamate concentrations increased malondialdehdye production in anesthetized rat brain cortex. Neurosci Lett 1998; 242: 1–4.
- Waterfall AH, Singh G, Fry JR, Marsden CA. Detection of the lipid peroxidation product malonaldehyde in rat brain in vivo. Neurosci Lett 1995; 200: 69–72.
- Griffiths R, Dunlop J, Gorman A, Senior J, Grieve A. L-trans-pyrrolidine-2,4-dicarboxylate and cis-1-aminocyclobutane-1,3-dicarboxylate behave as transportable competitive inhibitors of the high-affinity glutamate transporters. Biochem Pharmacol 1995; 47: 267–274.
- Qian H, Liu D. The time course of malondialdehyde production following impact injury to rat spinal cord as measured by microdialysis and high pressure liquid chromatography. Neurochem Res 1997; 22: 1231–1236.
- Kucukkaya B, Haklar G, Yalcin AS. NMDA excitotoxicity and free radical generation in rat brain homogenates: application of a chemiluminescence assay. Neurochem Res 1996; 21: 1535–1538.
- Lu YM, Yin HZ, Weiss JH. Ca' permeable AMPA/kainate channels permit rapid injurious Ca' entry. Neuroreport 1995; 6: 1089–1092.
- Carriedo SG, Sensi SL, Yin HZ, Weiss JH. AMPA exposures induced mitochondrial Ca' overload and ROS generation in spinal motor neurons in vitro. J Neurosci 2000; 20: 240–250.
- Kawasaki T, Yatsugi S, Ichiki C, Yatsugi S, Shimizu-Sasamata M, Yamaguchi T. YM90K, an AMPA receptor antagonist, protects against ischemic damage caused by permanent and transient middle cerebral artery occlusion in rats. Naunyn Schmiedeberg's Arch Pharmacol 1998; 358: 586–591.
- Le D, Das S, Wang YF et al. Enhanced neuronal death from focal ischemia in AMPA-receptor transgenic mice. Brain Res Mol Brain Res 1997; 52: 235–241.